Qiagen NV | QIA - Equity Capital And Reserves


Qiagen NV reported $3.36B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 25.02M 2.36M Jun/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
argenx SE USD 8.42B 1.09B Jun/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Moderna USD 6.76B 647M Jun/2026
Organon & Co USD 1.01B 103M Jun/2026
Qiagen NV USD 3.36B 26.03M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.26B 397.3M Jun/2026
Xeris Pharmaceuticals USD -9.73M 22.74M Jun/2026